☆ 4.8 Letter

The case for reverse engineering ketamine and psychedelics: lessons from translational oncology. A Response to Miller et al. Burning down the house: reinventing drug discovery in psychiatry for the development of targeted therapies

MOLECULAR PSYCHIATRY (2023)

Journal

MOLECULAR PSYCHIATRY

Volume -, Issue -, Pages -

Publisher

SPRINGERNATURE

DOI: 10.1038/s41380-023-02102-2

Keywords

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8

Not enough ratings

The case for reverse engineering ketamine and psychedelics: lessons from translational oncology. A Response to Miller et al. Burning down the house: reinventing drug discovery in psychiatry for the development of targeted therapies

Journal

MOLECULAR PSYCHIATRY

Publisher

SPRINGERNATURE

Keywords

Categories

Ask authors/readers for more resources

Protocol

Reagent

Authors

I am an author on this paper

Reviews

Primary Rating

Secondary Ratings

Novelty

Significance

Scientific rigor

Rate this paper

Recommended

The case for reverse engineering ketamine and psychedelics: lessons from translational oncology. A Response to Miller et al. Burning down the house: reinventing drug discovery in psychiatry for the development of targeted therapies

Journal

MOLECULAR PSYCHIATRY

Publisher

SPRINGERNATURE

Keywords

Categories

Ask authors/readers for more resources

Protocol

Reagent

Authors

I am an author on this paper

Reviews

Primary Rating

Secondary Ratings

Novelty

Significance

Scientific rigor

Rate this paper

Recommended

Export Citation

Share Paper